Recent research breakthroughs have revealed an intriguing and unexpected benefit of certain cancer drugs: the potential to protect against Alzheimer's disease. Originally developed for combating cancer, these medications have shown promise in preventing Alzheimer's in animal models such as mice,
MSD, also known as Merck in North America, has taken a significant step to enhance its therapeutic portfolio by investing $1.3 billion in the acquisition of CN201 from Curon Biopharmaceutical. The investigational bispecific antibody is poised to change the landscape of treatments for B-cell
The European Commission's recent authorization of Regeneron's bispecific antibody drug Ordspono (odronextamab) for the treatment of two types of lymphoma marks a significant milestone in the European market. Garnering approval for use across 27 European Union countries, Ordspono is now set to
The journey from a new chemical entity (NCE) to a marketable drug product is a complex, multifaceted process that demands an intricate blend of scientific expertise and practical knowledge. The transformation involves a deep understanding of organic chemistry, analytical development, pharmaceutical
Understanding the critical skills required in drug product formulation is pivotal for professionals in the pharmaceutical industry. This comprehensive domain encompasses various stages in the drug development process, demanding a multidisciplinary skill set that includes a robust foundation in
The U.S. Food and Drug Administration (FDA) has recently given its stamp of approval to updated COVID-19 vaccines from Pfizer and Moderna, marking a significant advancement in the ongoing efforts to combat the virus. These newly formulated vaccines are specifically designed to target the currently
